Structures by: Mitkin O. D.
Total: 5
N,N,5-Trimethyl-3-(phenylsulfonyl)-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyrimidin-amine
C18H20N4O2S
Journal of medicinal chemistry (2010) 53, 14 5186-5196
a=8.7051(5)Å b=16.7415(10)Å c=11.6695(6)Å
α=90.00° β=98.996(5)° γ=90.00°
N,5-Dimethyl-3-(phenylsulfonyl)-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyrimidin-2-amine
C17H18N4O2S
Journal of medicinal chemistry (2010) 53, 14 5186-5196
a=8.187(4)Å b=10.274(5)Å c=11.169(5)Å
α=116.031(11)° β=92.445(10)° γ=108.955(10)°
Ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2<i>H</i>-1,2,6-thiadiazine-4-carboxylate
C15H22N4O5S
Acta Crystallographica Section E (2020) 76, 1 12-17
a=12.4962(5)Å b=9.9237(4)Å c=29.5925(15)Å
α=90° β=90° γ=90°
C19H17NO2
C19H17NO2
Journal of Organic Chemistry (2007) 72, 6091-6096
a=8.8222(14)Å b=32.448(5)Å c=10.4880(16)Å
α=90.00° β=90.097(2)° γ=90.00°
Methyl 2-oxo-5,5-diphenyl-5,6-dihydropyridine-1(2H)-carboxylate
C19H17NO3
Journal of the American Chemical Society (2006) 128, 12743-12749
a=14.2376(14)Å b=8.0308(8)Å c=14.7680(15)Å
α=90.00° β=116.5600(10)° γ=90.00°